Regarding the questions about why early detection is important, I was doing some digging into Cognoa’s product and their 2021 FDA approval, and found this PR NewsWire story which gives some good detail about why early diagnosis & intervention is important, and how automated tools can allow earlier intervention, as well as boosting the reliability of diagnosis. Another important angle of the technological approach to diagnosis (apps etc) is that it can even the playing field for underrepresented demographics (namely females and non-whites) as well as deprived folks who get diagnosed much later (if ever).
Anyway I thought I’d share the link here, as it helps add substance to the narrative - that is to say, to assess if BB1 has a compelling idea that the world needs & wants. Would be interesting to see how Cognoa’s (and any other competitors’) products are faring in the market, given that Cognoa got FDA approval nearly 3 years ago, and BB1 is still years away from achieving it.
https://www.prnewswire.com/news-releases/cognoa-receives-fda-marketing-authorization-for-first-of-its-kind-autism-diagnosis-aid-301304351.html
Also, a piece about EarliTech Diagnostics’s 2022 FDA approval, that goes into why early detection is a good thing: https://www.fiercebiotech.com/medtech/fda-clears-digital-tool-help-doctors-diagnose-autism-kids-young-16-months
- Forums
- ASX - By Stock
- BB1
- The float
The float, page-61
-
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BB1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.5¢ |
Change
-0.005(1.79%) |
Mkt cap ! $15.69M |
Open | High | Low | Value | Volume |
28.5¢ | 28.5¢ | 27.5¢ | $17.67K | 63.64K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 42703 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 74725 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 39000 | 0.270 |
1 | 29754 | 0.265 |
1 | 10000 | 0.255 |
2 | 30000 | 0.250 |
2 | 120833 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 74725 | 1 |
0.295 | 20000 | 1 |
0.330 | 15002 | 1 |
0.340 | 39501 | 2 |
0.345 | 2500 | 1 |
Last trade - 14.47pm 04/10/2024 (20 minute delay) ? |
Featured News
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
BB1 (ASX) Chart |